Bayern Munich’s outcast Bryan Zaragoza remains in limbo as he searches for a new club after being informed that he will not be involved with the German champions’ activities for the 2026/27 season. The former Granada winger has drawn interest from several teams, with two La Liga outfits reportedly exploring a potential move: Sevilla and Alavés are both eyeing Zaragoza, while Espanyol are also keeping tabs on the situation. However, any interested club is proceeding with caution, prioritizing the medical risk before making an offer. Zaragoza has been sidelined for more than two months due to knee inflammation, prompting scrutiny of his fitness and whether he can withstand a transfer. Sevilla, in particular, see him as a suitable fit but want to confirm that his knee is robust enough to support a loan with an option to buy before submitting a formal bid. The situation has been chronicled by Orgullo Biri on X, with coverage noting that a transfer would hinge on a favorable medical assessment.
If Bayern manages to move Zaragoza to one of these clubs or any other, it would mark a significant step for Max Eberl in his ongoing effort to offload surplus players and reshape the squad. The ongoing evaluation of Zaragoza’s medical condition remains central to any potential deal, as clubs weigh the risk against the potential contribution the winger could offer once fully match-fit. For Zaragoza, the clock is ticking as he seeks a new environment where he can revive his career and prove his value on the field after the setback of extended knee issues. The broader objective for Bayern and their recruitment department is to streamline the roster and reduce excess personnel, a task that becomes easier if a suitable buyer is found for Zaragoza. The next weeks will be telling, with medical reports likely to influence any definitive negotiation points, such as loan terms, options to buy, and potential transfer fees.
Content Source: Yahoo News
Image Credit: Getty Images
All rights to the news content and images belong to their respective copyright owners.